« Back to Record
Awada, A., Thödtmann, R., Piccart-Gebhart, M., Wanders, J., Schrijvers, A. H. G. J., Von Broen, I.-M., Hanauske, A.-R., & EORTC-ECSG phase I study, (2003). An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours. European journal of cancer, 39(6), 742-747.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53698



